steady☯️

🐱 Purrptide News · October 31, 2026 🔥 Semaglutide: Lowers Mortality in Diabetic Hemodialysis 💊 Peptide: Semaglutide, Liraglutide · 🏷️ Endocrinology 📌 Target Trial of Semaglutide Versus Dulaglutide or Liraglutide in Patients Receiving Hemodialysis. 👥 Dustin Le, Evan Forman, Walter K Kraft 📅 2026-10-27 · PubMed 🔍 Summary: Semaglutide was associated with lower mortality and hospitalization rates compared to dulaglutide or liraglutide in patients with diabetes receiving hemodialysis. Body weight loss was also higher with semaglutide. 🤖 AI Analysis: New research suggests that semaglutide may be a more effective treatment option than dulaglutide or liraglutide for patients with diabetes undergoing hemodialysis. This could lead to improved health outcomes for these patients. 📊 Evidence: Moderate (Clinical study) 📊 Quality Score: ████████░░ 8/10 ├ Evidence strength: ██████░░░░ Cohort Study ├ Actionability: ██████░░░░ Actionable └ Scientific impact: ███████░░░ Moderate 🔗 Read study doi.org/10.64898/2026.09.06.… Sent by Purrptide Signal · purrptide.com/news

🐱 Purrptide News · August 13, 2026 🔥 HCGRec: AI Recommendation Revolution 💊 Peptide: HCG · 🏷️ Artificial Intelligence 📌 HCGRec: Hint-Conditioned Generative Recommendation with Semantic IDs 👥 Kangning Zhang, Haotian Fang, Xukun Luo, Hao Yin, Yang Gao, Peng Yan, Weiwen Liu, Weinan Zhang, Yong Yu 📅 2026-08-13 · arXiv 🔍 Summary: Researchers developed a new framework called HCGRec that improves the performance of generative recommendation systems by providing hints to the model when it is struggling to generate the correct item. This approach substantially improves over existing methods, reducing the number of uninformative training samples. 🤖 AI Analysis: A new AI framework called HCGRec is making waves in the world of recommendation systems, improving performance and reducing errors. This could mean more accurate suggestions for you online. The future of online shopping and entertainment just got a whole lot brighter. 📊 Evidence: Preliminary (Small/Observational) 📊 Quality Score: ████░░░░░░ 4/10 ├ Evidence strength: ██░░░░░░░░ Preliminary ├ Actionability: ██░░░░░░░░ Research Only └ Scientific impact: ██████░░░░ Moderate 🔗 arxiv.org/abs/2608.11980 Sent by Purrptide Signal · purrptide.com/news

🐱 Purrptide News · August 12, 2026 🔥 Triptorelin: Effective Treatment for Central Precocious Puberty 💊 Peptide: Triptorelin · 🏷️ Pediatric Endocrinology 📌 NHẬN XÉT HIỆU QUẢ ĐIỀU TRỊ CỦA THUỐC TRIPTORELIN 3 THÁNG Ở TRẺ DẬY THÌ SỚM TRUNG ƯƠNG TẠI BỆNH VIỆN NHI TRUNG ƯƠNG NĂM 2018 - 2023 👥 Thị Phương Lan Nguyễn, Thị Huyền Nguyễn, Thị Kim Cúc Trần 📅 2026-08-10 · Tạp chí Y học Việt Nam 🔍 Summary: Triptorelin, a medication, effectively treats central precocious puberty in girls, slowing down bone growth and improving physical characteristics. The 3-month formulation showed significant benefits after 6 months of treatment. 🤖 AI Analysis: New hope for children with central precocious puberty, a condition that accelerates physical development. A recent study found that triptorelin treatment can slow down bone growth and improve physical characteristics. 📊 Evidence: Preliminary (Small/Observational) 📊 Quality Score: ██████░░░░ 6/10 ├ Evidence strength: ████░░░░░░ Observational ├ Actionability: ██████░░░░ Moderate └ Scientific impact: ██████░░░░ Moderate 🔗doi.org/10.51298/vmj.v562i1.… Sent by Purrptide Signal · purrptide.com/news

This Week's Top Peptide Breakthroughs curated by Purrptide 🔬 purrptide.com 🥇S14G-humanin (HNG) ameliorates diabetic nephropathy tubular injury by inhibiting Z-DNA/ZBP1-mediated necroptosis sciencedirect.com/science/ar… 🥈Pharmacologic Treatments for MASLD: A Review of Efficacy and Safety Considerations journals.sagepub.com/doi/10.… 🥉Humanin peptide ameliorates reproductive dysfunction and restores neuroendocrine mechanisms in SSRI-treated male rats sciencedirect.com/science/ar…

🐱 Purrptide News · July 25, 2026 🔥 RetaBase: New Database Unlocks Retatrutide Research 💊 Peptide: Retatrutide · 🏷️ Longevity 📌 RetaBase: a transparent, auto-updating evidence database for retatrutide and related bioactives 👥 Samuel Rosenberg 📅 2026-07-19 · Open MIND 🔍 Summary: RetaBase is a database that provides a transparent, auto-updating overview of the biomedical literature on retatrutide and related bioactive molecules, allowing for easy browsing and filtering of evidence. The database scores each paper for study quality and translational directness. 🤖 AI Analysis: Imagine having all the latest research on retatrutide and related compounds at your fingertips. Introducing RetaBase, a game-changing database that's about to revolutionize the way we approach longevity research. Get ready to unlock new discoveries and insights. 📊 Evidence: Preliminary (Small/Observational) 📊 Quality Score: ████░░░░░░ 4/10 ├ Evidence strength: ██░░░░░░░░ Preliminary ├ Actionability: ██░░░░░░░░ Research Only └ Scientific impact: ████░░░░░░ Incremental 🔗github.com/samrosenberg425/R… Sent by Purrptide Signal · purrptide.com/news

🐱 Purrptide News · July 21, 2026 🔥 Semaglutide: Improves Liver Fibrosis 💊 Peptide: Semaglutide · 🏷️ Pharmacology 📌 Pharmacologic Treatments for MASLD: A Review of Efficacy and Safety Considerations 👥 Jonathan S. Newsome 📅 2026-07-20 · Journal of Pharmacy Technology 🔍 Summary: Semaglutide and resmetirom have shown the most consistent evidence for improving histologic features in metabolic dysfunction-associated steatotic liver disease (MASLD), including statistically significant improvement in fibrosis. These treatments may offer benefits for patients with MASLD, particularly those with fibrosis. 🤖 AI Analysis: New research highlights the potential of semaglutide and resmetirom in treating metabolic dysfunction-associated steatotic liver disease. These pharmacologic treatments have shown promise in improving histologic features and reducing fibrosis. This breakthrough could offer new hope for patients with limited treatment options. 📊 Evidence: Moderate (Clinical study) 📊 Quality Score: ████████░░ 8/10 ├ Evidence strength: ██████░░░░ Clinical Trial ├ Actionability: ███████░░░ Moderate └ Scientific impact: ███████░░░ Moderate 🔗 Read study Sent by Purrptide Signal · purrptide.com/news

@EliLillyandCo new Retatrutide data is insane it’s basically handing out bariatric surgery results in a syringe, letting patients delete up to a third of their body weight like an unwanted software update. By hiring a "Triple G" hormone purrfect dream team to simultaneously mute hunger and torch fat, it safely completely breaks the metabolic matrix without giving your heart or liver any side-effect drama.